AIDS · 2002 · 81 citations · 18 references
These data may be exploitable to further improve sanctuary site concentrations of anti-HIV or anti-cancer drugs by using ritonavir as a lead compound to develop more potent MRP-1 inhibitors.
18
V. Venkat Rao, Julie L. Dahlheimer, Mark E. Bardgett et al. · Proceedings of the National Academy of Sciences · 1999 · 525 citations · Full text
Cellular Pharmacology, Cellular Physiology, Drug Resistance +16
HIV-1 Protease Inhibitors Are Substrates for the<i>MDR</i>1 Multidrug Transporter
Caroline Lee, Michael M. Gottesman, Carol Cardarelli et al. · Biochemistry · 1998 · 481 citations
Tissue distribution of the multidrug resistance protein.
M J Flens, G J Zaman, Paul van der Valk et al. · PubMed · 1996 · 477 citations